Work

5507 ORAL A phase 2 study of axitinib (AG-013736; AG) in patients (pts) with advanced thyroid cancers

Year: 2007

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(07)71224-7

Authors: E. Cohen, E.E. Vokes, L.S. Rosen, M.S. Kies, A.A. Forastiere, F.P. Worden, M.A. Kane, K.F. Liau, D.R. Shalinsky, R.B. Cohen

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2133388512

Cites:

Cited by: 1

Related to: 10